Top compounds associated with response to DEFB106B

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.017	0.6
mRNA	BRD-K24690302	CTRPv2	pan-cancer	AAC	0.018	0.6
mRNA	PF-3758309	CTRPv2	pan-cancer	AAC	0.021	0.6
mRNA	regorafenib	CTRPv2	pan-cancer	AAC	-0.018	0.6
mRNA	QW-BI-011	CTRPv2	pan-cancer	AAC	-0.034	0.6
mRNA	Erlotinib	CTRPv2	pan-cancer	AAC	-0.017	0.6
mRNA	BMS-195614	CTRPv2	pan-cancer	AAC	-0.019	0.6
mRNA	JQ-1:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.017	0.6
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.015	0.6
mRNA	BRD-K13999467	CTRPv2	pan-cancer	AAC	-0.017	0.6

Download CSV